NCOA3 and pancreatic neoplasm: Copy number alterations and point mutations in NCOA3 (AIB1) have been observed in human breast (31%) and CRCs (14%) [39, 42] and it is a transposon target in murine models of colorectal, liver, pancreas cancer, and melanoma [39, 43].